Two-year persistence with teriparatide improved significantly after introduction of an educational and motivational support program.
M A van MarenCaroline E WyersJ H M DriessenJ V VisserF de VriesK van de WijdevenS GeversW F LemsM H Emmelot-VonkJ P W van den BerghPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2019)
The introduction of the EMSP has demonstrated to improve the persistence with TPTD, resulting in 78% of the patients being persistent with TPTD during the 2-year treatment period.